Enabling personalized medicine in Europe by the European Commission's funding activities

Personalized Medicine
Elmar NimmesgernRuxandra Draghia-Akli

Abstract

Personalized medicine (PM) is an emerging approach to prevention, diagnosis, treatment and care. It helps to address the challenge of the aging of the population, an increase in chronic disease and increasing healthcare costs. The EU is developing policies to move toward PM. This is underpinned by a sustained and significant investment starting in 2010. So far, a total of €3.2 billion has been invested in PM research across the medical innovation cycle 'from bench to bedside'. This investment has come from the research framework programs FP7 and Horizon 2020. About a third of the total investment has been made in the context of the Innovative Medicines Initiative, the largest public-private partnership in life sciences globally.

References

Jul 3, 2004·BMJ : British Medical Journal·Munir PirmohamedAlasdair M Breckenridge
Feb 4, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cornelis S van der HooftBruno H Ch Stricker
Jun 2, 2010·Journal of the Royal Society of Medicine·Tai-Yin WuAzeem Majeed
Jul 6, 2014·Fundamental & Clinical Pharmacology·Anne Bénard-LaribièreUNKNOWN EMIR Study Group on behalf of the French network of pharmacovigilance centres
Nov 8, 2015·European Journal of Clinical Pharmacology·Consuelo PedrósJosep Maria Arnau
Jun 28, 2016·Nature Communications·Emanuele LibertiniStephan Beck
Jun 28, 2016·Nature Biotechnology·Emanuele LibertiniStephan Beck
Aug 25, 2016·The New England Journal of Medicine·Fatima CardosoUNKNOWN MINDACT Investigators
Jan 14, 2017·Clinical and Translational Science·E NimmesgernI Norstedt

❮ Previous
Next ❯

Citations

May 2, 2018·Personalized Medicine·Adam Tarring
May 19, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Greg ScuttChakravarthi Rajkumar
Jan 9, 2021·Behavioural Brain Research·Jose M RubioJohn M Kane
Jul 27, 2021·Current Therapeutic Research, Clinical and Experimental·Davide GrisafiFrancesco Scaglione

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

BIOPRED
IMI2
IC PerMed
InSPiRe
BLUEPRINT
GAPVAC
INNODIA
PerMed
IDeAl
ASTERIX

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Heico J FrimaMaj-Inger Nilsson
European Heart Journal
Karin R Sipido, Frans Van de Werf
© 2022 Meta ULC. All rights reserved